PEPTIDE

Independent prescriber clinic

Research Supply (Not a clinic) — Type H

Jurisdiction: InternationalLast updated: 15 April 2026

Research-compound supply operations are NOT clinics. They sell research-use materials, often online and often from outside Australia. Including here for completeness — none of these route is appropriate for human use.

Trust score

0.0 / 5
  • Medical oversight0.0 / 5
  • Transparency0.0 / 5
  • Access clarity0.0 / 5
  • Pricing clarity0.0 / 5
  • Support clarity0.0 / 5
  • Aftercare0.0 / 5

Strengths

  • None — this category is not a clinical pathway

Concerns

  • No medical oversight
  • No aftercare
  • Compound is not approved for human use
  • Marketing for human-use outcomes is unlawful and unsafe
  • Often international supply with no Australian recourse

Editorial review

Research-compound suppliers explicitly are not clinics. They have no prescriber, no medical oversight, and no aftercare. We include this category in the comparison only to make the boundary unambiguous: research-use supply is not a treatment pathway.

Within research supply itself, transparency varies enormously — see our supplier transparency reviews for evaluation criteria.

If a website mixes 'research-only' framing with marketing aimed at human-use outcomes (weight loss, muscle gain, anti-ageing), it's operating outside both the research-supply and the clinical-prescribing boundaries. That's the highest-risk position from a regulatory and personal-safety standpoint.

Compounds typically prescribed

  • Research compounds — not for human use
  • Laboratory reagent supply

FAQs

Because readers ask. The answer should be unambiguous: research supply is not a treatment pathway. If you have a clinical reason to consider a peptide, the right next step is one of categories A–G above, with a real medical conversation.

Comparing models? Browse the full clinic hub.

See all clinic profiles